SCHEMBL4375386

SCHEMBL4375386

CC(C)(C)C(NC(=O)O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.43
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 2/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HPGD P15428 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382189 1.00 ACKR3 (0.43) ACKR3MEN1KMT2AMAPTGAA
SCHEMBL4378512 0.84 AKT1 (0.40) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL4583485 0.83 ALDH1A1 (0.47) MEN1KMT2ALMNAALDH1A1L3MBTL1
SCHEMBL4374524 0.83 ALDH1A1 (0.47) MEN1KMT2ALMNAALDH1A1L3MBTL1
SCHEMBL4373621 0.83 AKT1 (0.39) KMT2A
SCHEMBL4380031 0.83 AKT1 (0.39) KMT2A
SCHEMBL4384197 0.82 HDAC1 (0.47) ACKR3MEN1KMT2AMAPTGAA
SCHEMBL4377324 0.81 PYGL (0.38) KMT2AL3MBTL1RAB9ANPC1CTSL
SCHEMBL4582450 0.80 CTRB1 (0.38) KMT2ALMNARAB9ANPC1CTSL
SCHEMBL4379225 0.79 ANPEP (0.36) KMT2AL3MBTL1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2117523-A1 INHIBITORS OF AKT ACTIVITY SmithKline Beecham Corporation (US) 2009-11-18 EP disclosed
WO-2008098104-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2008-08-14 WO disclosed